We are live on !
Find out more
Brown Advisory Portfolio holdings
AUM
$64.6B
Turnover
14.74%
1-Year Est. Return
18.98%
This Fund
S&P 500
This Quarter Est. Return
+5.81%
1 Year Est. Return
+18.98%
3 Year Est. Return
+84.85%
5 Year Est. Return
+98.36%
10 Year Est. Return
+536.38%
AUM
$32.7B
AUM Growth
+$3.39B
(+12%)
Cap. Flow
+$2.01B
Cap. Flow % of AUM
Cap. Flow %
6.14%
Top 10 Holdings %
Top 10 Hldgs %
20.34%
Holding
1,273
New
114
Increased
570
Reduced
394
Closed
56
Avg Time Held
Equity + Options
2.3
years
Top 10 Avg Time Held
Equity + Options
1.3
years
Top 20 Avg Time Held
Equity + Options
1.6
years
Avg Time Held Equity only
2.3
years
Top 10 Avg Time Held Equity only
1.3
years
Top 20 Avg Time Held Equity only
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$437M |
| 2 |
Intuit
INTU
|
+$333M |
| 3 |
Mastercard
MA
|
+$203M |
| 4 |
Booking.com
BKNG
|
+$186M |
| 5 |
Alibaba
BABA
|
+$155M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$290M |
| 2 |
Akamai
AKAM
|
+$278M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$264M |
| 4 |
Cognizant
CTSH
|
+$252M |
| 5 |
Acuity Brands
AYI
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.24% |
| 2 | Financials | 17.03% |
| 3 | Healthcare | 14.75% |
| 4 | Consumer Discretionary | 12.2% |
| 5 | Communication Services | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Visa
V
$759B
| $1.05B | 3.21% |
11,194,784
+422,164
| +4% | +$39.2M |
2013 Q2
16 quarters
|
|
2
Meta Platforms (Facebook)
META
$1.61T
| $821M | 2.51% |
5,440,163
+111,783
| +2% | +$16.6M |
2013 Q2
16 quarters
|
|
3
Alphabet (Google) Class C
GOOG
$3.84T
| $756M | 2.31% |
16,646,780
+1,292,000
| +8% | +$59.1M |
2013 Q2
16 quarters
|
|
4
Amazon
AMZN
$2.69T
| $626M | 1.91% |
12,924,000
-3,101,700
| -19% | -$148M |
2013 Q2
16 quarters
|
|
5
Danaher
DHR
$164B
| $617M | 1.88% |
8,242,021
+388,021
| +5% | +$29M |
2013 Q2
16 quarters
|
|
6
PayPal
PYPL
$47B
| $596M | 1.82% |
11,109,914
+424,409
| +4% | +$20.9M |
2015 Q3
7 quarters
|
|
7
Edwards Lifesciences
EW
$52.2B
| $564M | 1.72% |
14,300,199
+1,010,187
| +8% | +$36.9M |
2013 Q2
16 quarters
|
|
|
8
Mastercard
MA
$537B
| $554M | 1.69% |
4,560,615
+1,711,811
| +60% | +$203M |
2013 Q2
16 quarters
|
|
9
Adobe
ADBE
$101B
| $539M | 1.65% |
3,813,404
-319,862
| -8% | -$43.8M |
2013 Q2
16 quarters
|
|
10
Intuitive Surgical
ISRG
$160B
| $530M | 1.62% |
5,104,341
-699,804
| -12% | -$67.3M |
2013 Q2
16 quarters
|
|
11
Ecolab
ECL
$81B
| $501M | 1.53% |
3,775,116
-302,743
| -7% | -$39.1M |
2013 Q2
16 quarters
|
|
12
Roper Technologies
ROP
$43.7B
| $486M | 1.49% |
2,100,546
-17,919
| -0.8% | -$3.97M |
2013 Q2
16 quarters
|
|
13
Amphenol
APH
$186B
| $485M | 1.48% |
52,597,184
-1,062,032
| -2% | -$9.7M |
2013 Q2
16 quarters
|
|
|
14
Zoetis
ZTS
$33.5B
| $466M | 1.42% |
7,464,770
+7,398,139
| +11,103% | +$437M |
2014 Q4
10 quarters
|
|
15
TJX Companies
TJX
$158B
| $452M | 1.38% |
12,512,186
+2,541,834
| +25% | +$95.8M |
2013 Q2
16 quarters
|
|
16
Salesforce
CRM
$204B
| $441M | 1.35% |
5,095,064
-128,201
| -2% | -$11.2M |
2013 Q2
16 quarters
|
|
17
Alphabet (Google) Class A
GOOGL
$3.87T
| $436M | 1.33% |
9,381,520
+780,120
| +9% | +$36.5M |
2015 Q4
6 quarters
|
|
18
Apple
AAPL
$5.02T
| $432M | 1.32% |
11,987,492
+2,952,112
| +33% | +$109M |
2013 Q2
16 quarters
|
|
19
Fortive
FTV
$18.4B
| $431M | 1.32% |
10,784,870
-95,189
| -0.9% | -$3.75M |
2016 Q3
3 quarters
|
|
20
Microsoft
MSFT
$3.95T
| $424M | 1.3% |
6,148,985
+1,166,763
| +23% | +$80.1M |
2013 Q2
16 quarters
|
|
21
Costco
COST
$445B
| $421M | 1.29% |
2,630,993
-271,082
| -9% | -$46.7M |
2013 Q2
16 quarters
|
|
|
22
Booking.com
BKNG
$115B
| $414M | 1.26% |
5,530,700
+2,540,750
| +85% | +$186M |
2013 Q2
16 quarters
|
|
23
NXP Semiconductors
NXPI
$62B
| $407M | 1.24% |
3,720,525
-567,019
| -13% | -$60.7M |
2014 Q4
10 quarters
|
|
24
SBA Communications
SBAC
$19.7B
| $407M | 1.24% |
3,018,468
-262,511
| -8% | -$34.1M |
2013 Q2
16 quarters
|
|
25
Thermo Fisher Scientific
TMO
$253B
| $397M | 1.21% |
2,273,549
+70,947
| +3% | +$11.9M |
2013 Q2
16 quarters
|
|
Similar funds
Brown Advisory's Q2 2017 Portfolio in Review
As of Q2 2017, Brown Advisory held 1,273 positions worth $32.7B, up 12% from $29.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Brown Advisory deployed $2.01B of net new capital in Q2 2017, opening 114 new positions and adding to 570 existing holdings. Its largest new stake was Altaba Inc: 2,311,186 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $290M trimmed.
- Brown Advisory's largest Q2 2017 buy was Altaba Inc: 2,311,186 shares worth $126M.
- Brown Advisory added most to Zoetis in Q2 2017, an estimated $437M increase.
- Brown Advisory's biggest Q2 2017 reduction was Alexion Pharmaceuticals, cutting an estimated $290M.
- Brown Advisory fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $264M.
- Brown Advisory's ten largest holdings make up 20% of its $32.7B portfolio in Q2 2017.
- Brown Advisory opened 114 new positions and closed 56 in Q2 2017.
- Brown Advisory's portfolio value rose 12% quarter-over-quarter to $32.7B.
Based on Brown Advisory's 13F filing for Q2 2017, filed 14 Aug 2017.